Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
Perry, James R, Bélanger, Karl, Mason, Warren P, Fulton, Dorcas, Kavan, Petr, Easaw, Jacob, Shields, Claude, Kirby, Sarah, Macdonald, David R, Eisenstat, David D, Thiessen, Brian, Forsyth, Peter, Pouliot, Jean-François
Published in Journal of clinical oncology (20.04.2010)
Published in Journal of clinical oncology (20.04.2010)
Get full text
Journal Article
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors
Elkrief, Arielle, El Raichani, Layal, Richard, Corentin, Messaoudene, Meriem, Belkaid, Wiam, Malo, Julie, Belanger, Karl, Miller, Wilson, Jamal, Rahima, Letarte, Nathalie, Wong, Philip, Routy, Bertrand
Published in Oncoimmunology (03.04.2019)
Published in Oncoimmunology (03.04.2019)
Get full text
Journal Article
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Stupp, Roger, Dr, Hegi, Monika E, PhD, Mason, Warren P, MD, van den Bent, Martin J, MD, Taphoorn, Martin JB, Janzer, Robert C, MD, Ludwin, Samuel K, MD, Allgeier, Anouk, PhD, Fisher, Barbara, MD, Belanger, Karl, MD, Hau, Peter, MD, Brandes, Alba A, MD, Gijtenbeek, Johanna, MD, Marosi, Christine, MD, Vecht, Charles J, MD, Mokhtari, Karima, PhD, Wesseling, Pieter, MD, Villa, Salvador, MD, Eisenhauer, Elizabeth, MD, Gorlia, Thierry, MSc, Weller, Michael, MD, Lacombe, Denis, MD, Cairncross, J Gregory, MD, Mirimanoff, René-Olivier, MD
Published in The lancet oncology (01.05.2009)
Published in The lancet oncology (01.05.2009)
Get full text
Journal Article
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
Tonneau, Marion, Nolin-Lapalme, Alexis, Kazandjian, Suzanne, Auclin, Edouard, Panasci, Justin, Benlaifaoui, Myriam, Ponce, Mayra, Al-Saleh, Afnan, Belkaid, Wiam, Naimi, Sabrine, Mihalcioiu, Catalin, Watson, Ian, Bouin, Mickael, Miller, Wilson, Hudson, Marie, Wong, Matthew K., Pezo, Rossanna C., Turcotte, Simon, Bélanger, Karl, Jamal, Rahima, Oster, Paul, Velin, Dominique, Richard, Corentin, Messaoudene, Meriem, Elkrief, Arielle, Routy, Bertrand
Published in Oncoimmunology (31.12.2022)
Published in Oncoimmunology (31.12.2022)
Get full text
Journal Article
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
Gorlia, Thierry, Dr, van den Bent, Martin J, MD, Hegi, Monika E, PhD, Mirimanoff, René O, MD, Weller, Michael, MD, Cairncross, J Gregory, MD, Eisenhauer, Elizabeth, MD, Belanger, Karl, MD, Brandes, Alba A, MD, Allgeier, Anouk, PhD, Lacombe, Denis, MD, Stupp, Roger, MD
Published in The lancet oncology (2008)
Published in The lancet oncology (2008)
Get full text
Journal Article
Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study
PETRELLA, Teresa M, TOZER, Richard, HAGERMAN, Linda, WALSH, Wendy, EISENHAUER, Elizabeth A, BELANGER, Karl, SAVAGE, Kerry J, WONG, Ralph, SMYLIE, Michael, KAMEL-REID, Suzanne, TRON, Victor, CHEN, Bingshu E, HUNDER, Naomi N
Published in Journal of clinical oncology (20.09.2012)
Published in Journal of clinical oncology (20.09.2012)
Get full text
Journal Article
Adult Medulloblastoma Demographic, Tumor and Treatment Impact since 2006: A Canadian University Experience
Quinones, Maria Camila, Bélanger, Karl, Lemieux Blanchard, Émilie, Lemieux, Bernard, Bahary, Jean-Paul, Masucci, Laura G., Roberge, David, Menard, Cynthia, Lambert, Carole, Berthelet, France, Moumdjian, Robert, Florescu, Marie
Published in Current oncology (Toronto) (14.08.2021)
Published in Current oncology (Toronto) (14.08.2021)
Get full text
Journal Article
phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
Thiessen, Brian, Stewart, Clinton, Tsao, Ming, Kamel-Reid, Suzanne, Schaiquevich, Paula, Mason, Warren, Easaw, Jacob, Belanger, Karl, Forsyth, Peter, McIntosh, Lynn, Eisenhauer, Elizabeth
Published in Cancer chemotherapy and pharmacology (01.01.2010)
Published in Cancer chemotherapy and pharmacology (01.01.2010)
Get full text
Journal Article
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma
Jamal, Rahima, Lapointe, Réjean, Cocolakis, Eftihia, Thébault, Paméla, Kazemi, Shirin, Friedmann, Jennifer E, Dionne, Jeanne, Cailhier, Jean-François, Bélanger, Karl, Ayoub, Jean-Pierre, Le, Huy, Lambert, Caroline, El-Hajjar, Jida, van Kempen, Léon C, Spatz, Alan, Miller, Jr, Wilson H
Published in Journal for immunotherapy of cancer (21.11.2017)
Published in Journal for immunotherapy of cancer (21.11.2017)
Get full text
Journal Article
Pseudo-Chemical Meningitis and the Malignant Transformation of an Epidermoid Cyst
Demuth, Stanislas, Lasry, David E., Obaid, Sami, Letourneau-Guillon, Laurent, Chassé, Michaël, Bélanger, Karl, Berthelet, France, Bojanowski, Michel W., Keezer, Mark R.
Published in Canadian journal of neurological sciences (01.09.2019)
Published in Canadian journal of neurological sciences (01.09.2019)
Get full text
Journal Article
Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report
Taillefer, Vincent-Thierry, Pigeon, Marjorie, Chen, Michelle, Larochelle, Catherine, Florescu, Marie, Bélanger, Karl, Adam, Jean-Philippe
Published in Journal of oncology pharmacy practice (01.09.2020)
Published in Journal of oncology pharmacy practice (01.09.2020)
Get more information
Journal Article
Prophylactic anticonvulsants for gliomas: a seven-year retrospective analysis
Lapointe, Sarah, Florescu, Marie, Nguyen, Dang K., Djeffal, Chanez, Bélanger, Karl
Published in Neuro-oncology practice (01.12.2015)
Published in Neuro-oncology practice (01.12.2015)
Get full text
Journal Article
A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial
Lee, Christopher W., Bélanger, Karl, Rao, Sanjay C., Petrella, Teresa M., Tozer, Richard G., Wood, Lori, Savage, Kerry J., Eisenhauer, Elizabeth A., Synold, Timothy W., Wainman, Nancy, Seymour, Lesley
Published in Investigational new drugs (01.06.2008)
Published in Investigational new drugs (01.06.2008)
Get full text
Journal Article
Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA)
Chang, Susan Marina, Zhang, Peixin, Cairncross, J. Gregory, Gilbert, Mark R., Bahary, Jean-Paul, Dolinskas, Carol, Aldape, Kenneth D., Chakravarti, Arnab, Schiff, David, Jaeckle, Kurt A., Brown, Paul D., Barger, Geoffrey, Werner-Wasik, Maria, Shih, Helen Alice, Brachman, David, Penas-Prado, Marta, Robins, H. Ian, Belanger, Karl, Schultz, Christopher J., Mehta, Minesh P.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Diversification benefits of cat bonds: An in‐depth examination
Demers‐Bélanger, Karl, Lai, Van Son
Published in Financial markets, institutions & instruments (01.12.2020)
Published in Financial markets, institutions & instruments (01.12.2020)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of Novel l-Nucleoside Analog Troxacitabine Given as a 30-Minute Infusion Every 21 Days
BELANGER, Karl, MOORE, Malcolm, BAKER, Sharyn D, DIONNE, Jeanne, MACLEAN, Martha, JOLIVET, Jacques, SIU, Lillian, SOULIERES, Denis, WAINMAN, Nancy, SEYMOUR, Lesley
Published in Journal of clinical oncology (15.05.2002)
Published in Journal of clinical oncology (15.05.2002)
Get full text
Journal Article
Phase II study of marimastat (BB-2516) in malignant melanoma: A clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group
QUIRT, Ian, BODURTHA, Audley, LOHMANN, Reinhard, RUSTHOVEN, James, BELANGER, Karl, YOUNG, Vincent, WAINMAN, Nancy, STEWARD, William, EISENHAUER, Elizabeth
Published in Investigational new drugs (01.11.2002)
Published in Investigational new drugs (01.11.2002)
Get full text
Journal Article
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Routy, Bertrand, Lenehan, John G., Miller, Wilson H., Jamal, Rahima, Messaoudene, Meriem, Daisley, Brendan A., Hes, Cecilia, Al, Kait F., Martinez-Gili, Laura, Punčochář, Michal, Ernst, Scott, Logan, Diane, Belanger, Karl, Esfahani, Khashayar, Richard, Corentin, Ninkov, Marina, Piccinno, Gianmarco, Armanini, Federica, Pinto, Federica, Krishnamoorthy, Mithunah, Figueredo, Rene, Thebault, Pamela, Takis, Panteleimon, Magrill, Jamie, Ramsay, LeeAnn, Derosa, Lisa, Marchesi, Julian R., Parvathy, Seema Nair, Elkrief, Arielle, Watson, Ian R., Lapointe, Rejean, Segata, Nicola, Haeryfar, S.M. Mansour, Mullish, Benjamin H., Silverman, Michael S., Burton, Jeremy P., Maleki Vareki, Saman
Published in Nature medicine (01.08.2023)
Published in Nature medicine (01.08.2023)
Get full text
Journal Article
Uveal melanoma: Real-world analysis of immune checkpoint inhibitors efficacy and lymphocyte-to-monocyte ratio as a biomarker of response
Desilets, Antoine, Beland, Chloe, Hladky, Valerie, Pang, Steph A., Elkrief, Arielle, Stepanov, Andreea, Routy, Bertrand, Belanger, Karl, Miller, Wilson H., Larochelle, Olivier, Jamal, Rahima
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article